Qube Research & Technologies (QRT)’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-44,369
Closed -$965K 3859
2025
Q4
$965K Buy
+44,369
New +$1.27M ﹤0.01% 2568
2024
Q2
Sell
-16,284
Closed -$913K 4336
2024
Q1
$913K Sell
16,284
-185,852
-92% -$11.2M ﹤0.01% 2194
2023
Q4
$12.2M Buy
202,136
+199,839
+8,700% +$12.7M 0.02% 667
2023
Q3
$154K Buy
+2,297
New +$160K ﹤0.01% 2504
2023
Q1
Sell
-22,154
Closed -$1.11M 2818
2022
Q4
$1.11M Sell
22,154
-85,137
-79% -$4.12M 0.01% 1184
2022
Q3
$4.38M Buy
+107,291
New +$5.04M 0.03% 661
2022
Q2
Sell
-30,032
Closed -$1.09M 2859
2022
Q1
$1.09M Buy
+30,032
New +$1.19M 0.01% 1132
2020
Q3
Sell
-4,833
Closed -$206K 1928
2020
Q2
$206K Buy
+4,833
New +$189K ﹤0.01% 1425

Other funds holding LEGN

Qube Research & Technologies (QRT)'s LEGN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 44,369 shares — an estimated $965K sold.

Qube Research & Technologies (QRT) first reported a position in LEGN in Q2 2020 and held it in 8 quarters. The position peaked at $12.2M in Q4 2023. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 44,369 Legend Biotech shares in Q1 2026, an estimated $965K.
  • Qube Research & Technologies (QRT) first reported a position in Legend Biotech in Q2 2020 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Legend Biotech position peaked at $12.2M in Q4 2023.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.